Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Long-COVID Syndrome | Research

Impact of vaccination and variants of concern on long COVID clinical phenotypes

Authors: Grace Kenny, Kathleen McCann, Conor O’Brien, Cathal O’Broin, Willard Tinago, Obada Yousif, Tessa O’Gorman, Aoife G. Cotter, John S. Lambert, Eoin R. Feeney, Eoghan de Barra, Corinna Sadlier, Alan Landay, Peter Doran, Stefano Savinelli, Patrick W. G. Mallon, The All Ireland Infectious Diseases Cohort Study

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Background

Defining patterns of symptoms in long COVID is necessary to advance therapies for this heterogeneous condition. Here we aimed to describe clusters of symptoms in individuals with long COVID and explore the impact of the emergence of variants of concern (VOCs) and vaccination on these clusters.

Methods

In a prospective, multi centre cohort study, individuals with symptoms persisting > 4 weeks from acute COVID-19 were divided into two groups based on timing of acute infection; pre-Alpha VOC, denoted wild type (WT) group and post-Alpha VOC (incorporating alpha and delta dominant periods) denoted VOC group. We used multiple correspondence analysis (MCA) and hierarchical clustering in the WT and VOC groups to identify symptom clusters. We then used logistic regression to explore factors associated with individual symptoms.

Results

A total of 417 individuals were included in the analysis, 268 in WT and 149 in VOC groups respectively. In both groups MCA identified three similar clusters; a musculoskeletal (MSK) cluster characterised by joint pain and myalgia, a cardiorespiratory cluster and a less symptomatic cluster. Differences in characteristic symptoms were only seen in the cardiorespiratory cluster where a decrease in the frequency of palpitations (10% vs 34% p = 0.008) and an increase in cough (63% vs 17% p < 0.001) in the VOC compared to WT groups was observed. Analysis of the frequency of individual symptoms showed significantly lower frequency of both chest pain (25% vs 39% p = 0.004) and palpitations (12% vs 32% p < 0.001) in the VOC group compared to the WT group. In adjusted analysis being in the VOC group was significantly associated with a lower odds of both chest pain and palpitations, but vaccination was not associated with these symptoms.

Conclusion

This study suggests changes in long COVID phenotype in individuals infected later in the pandemic, with less palpitations and chest pain reported. Adjusted analyses suggest that these effects are mediated through introduction of variants rather than an effect from vaccination.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kenny G, Mallon PW. COVID19- clinical presentation and therapeutic considerations. Biochem Biophys Res Commun. 2021;538:125–31.CrossRefPubMed Kenny G, Mallon PW. COVID19- clinical presentation and therapeutic considerations. Biochem Biophys Res Commun. 2021;538:125–31.CrossRefPubMed
3.
go back to reference Kenny G, McCann K, O’Brien C, et al. Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis. 2022;9: ofac060.CrossRefPubMedPubMedCentral Kenny G, McCann K, O’Brien C, et al. Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis. 2022;9: ofac060.CrossRefPubMedPubMedCentral
5.
7.
go back to reference Ayoubkhani D, Bermingham C, Pouwels KB, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676.CrossRefPubMed Ayoubkhani D, Bermingham C, Pouwels KB, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676.CrossRefPubMed
8.
go back to reference Twohig KA, Nyberg T, Zaidi A, et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis. 2022;22:35–42.CrossRefPubMedPubMedCentral Twohig KA, Nyberg T, Zaidi A, et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis. 2022;22:35–42.CrossRefPubMedPubMedCentral
9.
10.
go back to reference Kenny G, Negi R, O’Reilly S, et al. Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination. J Immunol Methods. 2022;510:113345.CrossRefPubMedPubMedCentral Kenny G, Negi R, O’Reilly S, et al. Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination. J Immunol Methods. 2022;510:113345.CrossRefPubMedPubMedCentral
12.
13.
go back to reference Blake C, Codd MB, O’Meara YM. The short form 36 (SF-36) Health Survey: normative data for the Irish population. Ir J Med Sci. 2000;169:195–200.CrossRefPubMed Blake C, Codd MB, O’Meara YM. The short form 36 (SF-36) Health Survey: normative data for the Irish population. Ir J Med Sci. 2000;169:195–200.CrossRefPubMed
14.
go back to reference Di Franco G. Multiple correspondence analysis: one only or several techniques? Qual Quant. 2016;50:1299–315.CrossRef Di Franco G. Multiple correspondence analysis: one only or several techniques? Qual Quant. 2016;50:1299–315.CrossRef
16.
go back to reference Althouse AD. Adjust for multiple comparisons? It’s not that simple. Ann Thorac Surg. 2016;101:1644–5.CrossRefPubMed Althouse AD. Adjust for multiple comparisons? It’s not that simple. Ann Thorac Surg. 2016;101:1644–5.CrossRefPubMed
17.
go back to reference Sahanic S, Tymoszuk P, Ausserhofer D, et al. Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey. Clin Infect Dis. 2022;75(1):e418–31. https://doi.org/10.1093/cid/ciab978. Sahanic S, Tymoszuk P, Ausserhofer D, et al. Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey. Clin Infect Dis. 2022;75(1):e418–31. https://​doi.​org/​10.​1093/​cid/​ciab978.
18.
go back to reference Frontera JA, Thorpe LE, Simon NM, et al. Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: a prospective, observational study. PLoS One. 2022;17:e0275274.CrossRefPubMedPubMedCentral Frontera JA, Thorpe LE, Simon NM, et al. Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: a prospective, observational study. PLoS One. 2022;17:e0275274.CrossRefPubMedPubMedCentral
19.
go back to reference Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13:1957.CrossRefPubMedPubMedCentral Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13:1957.CrossRefPubMedPubMedCentral
21.
go back to reference Magnusson K, Kristoffersen DT, Dell’Isola A, et al. Post-covid medical complaints following Infection with SARS-CoV-2 omicron vs Delta variants. Nat Commun. 2022;13:7363.CrossRefPubMedPubMedCentral Magnusson K, Kristoffersen DT, Dell’Isola A, et al. Post-covid medical complaints following Infection with SARS-CoV-2 omicron vs Delta variants. Nat Commun. 2022;13:7363.CrossRefPubMedPubMedCentral
22.
go back to reference Plante JA, Liu Y, Liu J, et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592:116–21.CrossRefPubMed Plante JA, Liu Y, Liu J, et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592:116–21.CrossRefPubMed
23.
go back to reference Puntmann VO, Martin S, Shchendrygina A, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 Illness. Nat Med. 2022;28:2117–23.CrossRefPubMedPubMedCentral Puntmann VO, Martin S, Shchendrygina A, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 Illness. Nat Med. 2022;28:2117–23.CrossRefPubMedPubMedCentral
24.
go back to reference Nehme M, Braillard O, Salamun J, et al. Symptoms after COVID-19 vaccination in patients with Post-acute Sequelae of SARS-CoV-2. J Gen Intern Med. 2022;37:1585–8.CrossRefPubMedPubMedCentral Nehme M, Braillard O, Salamun J, et al. Symptoms after COVID-19 vaccination in patients with Post-acute Sequelae of SARS-CoV-2. J Gen Intern Med. 2022;37:1585–8.CrossRefPubMedPubMedCentral
25.
go back to reference Antonelli M, Penfold RS, Merino J, et al. Risk factors and Disease profile of post-vaccination SARS-CoV-2 Infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43–55.CrossRefPubMedPubMedCentral Antonelli M, Penfold RS, Merino J, et al. Risk factors and Disease profile of post-vaccination SARS-CoV-2 Infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43–55.CrossRefPubMedPubMedCentral
Metadata
Title
Impact of vaccination and variants of concern on long COVID clinical phenotypes
Authors
Grace Kenny
Kathleen McCann
Conor O’Brien
Cathal O’Broin
Willard Tinago
Obada Yousif
Tessa O’Gorman
Aoife G. Cotter
John S. Lambert
Eoin R. Feeney
Eoghan de Barra
Corinna Sadlier
Alan Landay
Peter Doran
Stefano Savinelli
Patrick W. G. Mallon
The All Ireland Infectious Diseases Cohort Study
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08783-y

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine